Journal of the Korean Chemical Society (대한화학회지)

Korean Chemical Society (대한화학회)
권호 표지

O-Alkylation Using Ag2O; Synthesis of Novel 4-Alkyloxy-2-phenylcarboxamidyl-1-tosylpyrrolidines

산화은을 이용한 O-알킬화 반응; 새로운 4-알킬옥시-2-페닐카복사미딜-1-토실피롤리딘 유？체의 합성

  • 박명숙 (덕성여자대학교 약학대학)
  • Published : 20011200
Download PDF
⟨ Previous Next ⟩

Abstract

For the development of new COX-2 inhibitor, novel compound were synthesized through induction an arylsulfonyl group to 1-position, an arylcarboxamidyl group to 2-position and an alkyl group to 4-position of L-proline. We started from 4-hydroxy-L-proline, the 4-methylphenylsulfonyl of 1-position was introduced through N-tosylation and the carboxylic acid group was protected by esterification. We sucessfully converted to a various derivatives 4b-d for O-alkyl-(or aralkyl)ation of 4-position using silver oxide as catalysis. The 4-alkyloxy-1-tosyl L-prolines 5b-d were synthesized through base-hydrolysis for the deprotection of carboxylic acid. Final compound 1,2,4-substituted pyrrolidines, 4-alkyloxy-2-phenylcarboxamidyl-1-tosyl pyrrolidines 6a-d were synthesized through the condensation of arylamine with 3 and 5b-d using DCC.

새로운 COZ-2저해제를 개발하기 위하여 4-hydroxy L-proline의 1-위치에 arylsulfonyl기 2-위치에 arylcarboxamidyl기, 그리고 4-위치의hydroxy에 alkyl기를 도입한 새로운 후보 화합물을 합성하였다. 4-Hydroxy L-proline 1을 출발 물질로 하여 N-tosylation으로 1-위치에 4-methylphenylsulfonyl기를 도입하였고 esterification으로 carboxylic acid를 protection하였다. 4-위치의 O-alkyl-(or aralkyl)ation을 위해서 촉매로 silver oxide를 사용하여 다양한 유도체 4b-d로 전환시키는 데 성공하였다. Carboxylic acid기의 deprotection을 위해서 간편한 base-hydrolysis의 과정을 거쳐 4-alkyloxy-1-tosyl L-prolines 5b-d를 얻었다. 최종 목적 화합물인 1,2,4-치환된 pyrrolidine derivatives, 4-alkyloxy-2-phenylcarboxamidyl-1-tosyl pyrrolidines 6a-d 4종은 DCC를 사용하여 3 및 5b-d와 aniline과의 축합 반응으로 합성하였다.

Keywords

References

  1. In Goodman and Gilman’s The Pharmacological Basis of Therapeutics, (9th Ed.) Insel, P. A.;Hardman, J. G.(ed);Limbird, L. E.(ed);Molinoff, P. B.(ed);Ruddon, R. W.(ed);Gilman, A. G.(ed)
  2. In Nonsteroidal Antiinflammatory In Nonsteroidal Antiinflammatory Lombardino, J. G.
  3. In Anti-Inflammatory and Anti-Rheumatic Drugs v.Ⅰ Rainford, K. D.
  4. Nature(New Biol) v.231 no.232 Vane, J. R.
  5. Nature (New Biol) v.231 no.235 Smith, J. B.;Willis, A. L.
  6. Korean J. Med. Chem. v.8 no.48 Chang, H. W.;Jahang, Y.
  7. J. Biol. Chem. v.268 no.6610 Fletcher, B. S.;Smith, W. L.;DeWitt, D. L.
  8. Proc. Natl. Acad. Sci. v.91 no.11202 Copeland, R. A.;Williams, J. N.;Giannaras, J.;Nurnberg, S.;Covington, M.;Pinto, D.;Pick, S.
  9. U.S. Pat. v.4652582 Wilkerson, W. W.
  10. J. Med. Chem. v.37 no.988 Wilkerson, W. W.;Galbraith, W.;Gans-Brangs, K.;Grubb, M.;Hewes, W. E.;Jaffee, B.;Kenney, J. P.;Kerr, J.;Wong, N.
  11. J. Med. Chem. v.38 no.3895 Wilkerson, W. W.;Copeland, R. A.;Covinton, M.;Trzaskos, J. M.
  12. J. Med. Chem. v.41 no.1112 Janusz, J. M.;Young, P. A.;Ridgeway, J. M.;Scherz, M. W.
  13. Arzneim.-Forsch./Drug Res. v.46(Ⅱ) no.966 Kwon, S. K.;Park, M. S.
  14. J. Med. Chem. v.41 no.1124 Janusz, J. M.;Young, P. A.;Scherz, M. W.;Enzweiler, K.
  15. J. Med. Chem. v.37 no.3878 Reitz, D. B.;Li, J. J.;Norton, M. B.;Reinhard, E. J.;Collins, J. T.;Anderson, G. D.;Gregory, S. A.;Koboldt, C. M.;Perkins, W. E.;Seibert, K.;Isakson, P. C.
  16. J. Med. Chem. v.43 no.1661 Talley, J. J;Bertenshaw, S. R.;Carter, J. S.;Graneto, M. J.;Kellogg, M. S.;Koboldt, C. M.;Yuan, J.;Zhang, Y. Y.;Seibert, K.
  17. J. Med. Chem. v.43 no.775 Talley, J. J; Brown, D. L.;Carter, J. S.;Graneto, M. J.;Koboldt, C. M.;Masferrer, J. L.;Perkins, W. E.;Rogers, R. S.;Shaffer, A. F.;Zhang, Y. Y.;Zweifel, B. S.;Seibert, K.
  18. J. Med. Chem. v.43 no.3168 Khanna, I. K.;Yu, Y.;Huff, R. M.;Weier, R. M.;Xu, X.
  19. J. Med. Chem. v.43 no.214 Puig, C.;Crespo, M. I.;Godessart, N.;Feixas, J.;Ibarzo, J.;Jimenez, J. M.;Soca, L.;Cardelus, I.
  20. J. Med. Chem. v.40 no.1347 Penning, T. D.;Talley, J. J.;Bertenshaw, S. R.;Carter, J. S.;Collins, P. W.;Docter, S.;Graneto, M. J.;Lee, L. F.;Malecha, J. W.;Niyashiro, J. M.;Roger, R. S.;Rogier, D. J.;Yu, S. S.
  21. Celecoxib Drugs Future v.22 no.711
  22. J. Appl. Pharmacol. v.9 no.69 Kwon, S. K.
  23. 263339, Drug Data Report. v.20 no.6